Forte Biosciences CEO Paul Wagner's 2021 pay jumps 597% to $5.4M
Forte Biosciences reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
Forte Biosciences reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, two executives at Forte Biosciences received on average a compensation package of $3.6M, a 289% increase compared to previous year.
Average pay of disclosed executives at Forte Biosciences
Paul A. Wagner, Chief Executive Officer, received $5.4M in total, which increased by 597% compared to 2020. 81% of Wagner's compensation, or $4.4M, was in option awards. Wagner also received $163K in bonus, $590K in salary, as well as $295K in stock awards.
Antony Riley, Chief Financial Officer, received a compensation package of $1.8M, which increased by 67% compared to previous year. 60% of the compensation package, or $1.1M, was in option awards.
Related executives
You may also like
Source: SEC filing on April 29, 2022.